# BD MiniDraw™ Capillary System Clinical Equivalence Study

> **NCT05186311** · — · COMPLETED · sponsor: **Becton, Dickinson and Company** · enrollment: 262 (actual)

## Conditions studied

- Healthy
- Disease, Chronic
- Acute Disease
- Sample Collection

## Interventions

- **DEVICE:** Capillary Blood Collection System

## Key facts

- **NCT ID:** NCT05186311
- **Lead sponsor:** Becton, Dickinson and Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-22
- **Primary completion:** 2022-10-24
- **Final completion:** 2022-10-24
- **Target enrollment:** 262 (ACTUAL)
- **Last updated:** 2023-11-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05186311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05186311, "BD MiniDraw™ Capillary System Clinical Equivalence Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05186311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*